By selecting the Yes option, leaving Amgen.ie option you understand that you are leaving the corporate page of Amgen Ireland and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Europe is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Europe. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Amgen has established a long history of successfully inventing industry-leading technologies and investing in innovation to develop and manufacture biologic medicines for patients with serious illnesses.
At Amgen, we all rally to our common purpose of serving every patient, every time. This commitment requires us to innovate – to rethink how we manufacture, package and deliver products that reach patients when needed, and perform as needed. At every stage of the manufacturing process, we develop and implement innovative technologies to maximize efficiency, quality, safety, and sustainability in service of our mission.
Continuous Improvement is at the heart of everything we do. Every dollar and hour saved, can be used to advance our pipeline, improve - even further - our industry leading manufacturing, and enable us to supply our patients today, and more tomorrow.
Process development brings a promising molecule from research to clinical trials and beyond. Process development designs the manufacturing process for the small-scale production needed for clinical trials, the commercial-scale process needed to serve a larger population, and the technology required to make the drug in different facilities around the world.
Our manufacturing teams are responsible for making our drugs, first for clinical trials and then, if we receive regulatory approval, on a commercial scale. The manufacturing process varies for each product.
Our colleagues working in the supply chain teams ensure that we have the supply of quality raw materials needed to make our drugs—everything from chemicals and supplies to vials, devices, and packaging materials.
Amgen builds in quality, beginning with the design of medicines, all the way through to their development, manufacturing, and distribution to patients. We include more than 250 quality checks and perform in-depth analysis of our manufacturing performance to continuously improve it.
Our engineering team is responsible for managing the life cycle of Amgen’s physical assets, such as buildings, equipment, utilities, and instruments. They work to continuously to improve these resources so we can better serve our patients.
We have been at the forefront of the medical biotechnology revolution that started in the 1980s, helping invent the processes, methods and technologies that built the global biotechnology industry.